Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 7, 2021
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
Fri, June 4, 2021
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
Matthew Sykes Initiated (TWST) at Hold and Held Target at $110 on, Jun 4th, 2021
Matthew Sykes of Goldman Sachs, Initiated "Twist Bioscience Corporation" (TWST) at Hold and Held Target at $110 on, Jun 4th, 2021.
Matthew has made no other calls on TWST in the last 4 months.
There are 3 other peers that have a rating on TWST. Out of the 3 peers that are also analyzing TWST, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Steven Mah of "Piper Sandler" Initiated at Buy and Held Target at $150 on, Monday, April 12th, 2021
- Tycho Peterson of "JP Morgan" Downgraded from Hold to Sell and Held Target at $100 on, Friday, February 5th, 2021
- Catherine Schulte of "Baird" Maintained at Buy with Increased Target to $200 on, Friday, February 5th, 2021
